Lakeland Surgical and Diagnostic Center sets a new standard of care for a clean environment and reduces infection rates with the help of a germ-killing robot
LAKELAND, Florida – (COMMERCIAL THREAD) – In its ongoing commitment to patient safety, Lakeland Surgical and Diagnostic Center, LLP (LSDC) was the first outpatient surgery center (ASC) in Florida to deploy a LightStrike™ disinfection device. The Xenex LightStrike Germ eliminator robot™ rapidly destroys pathogens in operating rooms that can cause infections and pose a risk to patient safety. Since the deployment of two robots at the end of 2017, LSDC has seen a reduction in surgical site infection rates (SSI) at its two surgical sites.
“LSDC has a rigorous infection prevention program in place. Recognizing that pathogens that may pose a risk to patient safety are becoming resistant to cleaning chemicals, we have stepped up our disinfection efforts with the addition of LightStrike robots. The portable and powerful UV disinfection robot quickly destroys microscopic pathogens lurking on operating room surfaces that we cannot see, ”said Nikki Williams RN CNOR, Director of Operating Rooms at LSDC. “When it comes to infections, our goal is zero, which is why we are delighted to have seen a reduction in our rates of SSI, which were already very low.”
LightStrike robots harness the power of pulsed xenon to create intense, full-spectrum ultraviolet (UV) light that effectively
destroys hard-to-kill pathogens that can cause infections such as Staphylococcus aureus, Enterococcus, Klebsiella and Pseudomonas,
which are able to live on operating room (OR) surfaces from 1.5 hours to over 30 months, even after being cleaned with traditional methods. LSDC uses its robots to disinfect patient rooms, treatment areas and operating rooms after the day’s procedures are completed.
Always at the forefront of patient care and advanced technology, the two LSDC sites are the only facilities in Lakeland currently using this innovative technology. LightStrike robots have been credited in peer-reviewed studies by many health facilities to help them reduce their Clostridium difficile (C.diff), Methicillin-resistant Staphylococcus aureus (MRSA) and surgical site infection rate of 46% to 100%.
“The Lakeland Surgical & Diagnostic Center is committed to excellence. They are continually evaluating new technologies that can enable them to provide the best care for the patients they serve, and we are honored that our disinfection robots are part of their comprehensive infection prevention program. Due to their success in bringing down their already low SSI rates, we recognize them as a Visionary installation“said Irene Hahn, vice president of sales and account management at Xenex.
Due to its commitment to patient safety and its robust infection prevention program, Xenex has designated the Lakeland Surgical & Diagnostic Center as Visionary CSA. Visionary institutions are defined as those that 1. make patient safety a top priority; 2. Research and implement technologies with multiple proven results published in peer-reviewed publications; 3. Follow the best practices recommended by the manufacturer; 4. Publish and share the results to improve best practices for all health facilities; 5. Openly share their data for their benefit and the benefit of all mankind.
Xenex disinfection systems
Xenex LightStrike Germ-Zapping robots are used for advanced disinfection of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate easily into healthcare cleaning operations. Xenex’s mission is to save lives and reduce suffering by destroying deadly pathogens and superbugs that cause nosocomial infections (HAIs). The company is backed by well-known investors including EW Healthcare Partners, Piper Jaffray Merchant Services, Malin Corporation, Battery Ventures, Tectonic Ventures, Targeted Technology Fund II, and RK Ventures. For more information visit xenex.com.